88 results
8-K
EX-99.1
APRE
Aprea Therapeutics Inc
14 May 24
Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update
8:40am
.
Pipeline – lead candidate for a third synthetic lethality program to be selected in 2024
Aprea’s research and development team has identified a new … to an operating loss of $4.6 million in the comparable period in 2023.
Research and Development (R&D) expenses were $1.6 million for the quarter ended
8-K
EX-99.2
APRE
Aprea Therapeutics Inc
14 May 24
Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update
8:40am
; the future success of such trials; the successful implementation of our research and development programs and collaborations and the interpretation
8-K
EX-99.2
9mxez3
10 Apr 24
IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented
4:15pm
8-K
EX-99.1
ohvqazym2m
10 Apr 24
IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented
4:15pm
8-K
EX-99.2
k346bhk8
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
8-K
EX-99.1
jxxsknlkfyp40d4
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
8-K
EX-99.2
yykjk9npyqv24d ipd
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
8-K
EX-99.1
drpp2a m2
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
424B3
tfp5ql9 rqvxa9
9 Feb 24
Prospectus supplement
12:00am
8-K
EX-99.1
2j8fan4zet38wlmn
6 Feb 24
Other Events
5:01pm
424B3
jf3kahup xs
5 Feb 24
Prospectus supplement
12:00am
8-K
EX-99.1
um4nd6
4 Jan 24
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4:16pm
8-K
EX-99.2
da9dzyehory7b3gb9
4 Jan 24
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4:16pm
8-K
EX-99.1
wqyismh5 pgyys
9 Nov 23
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:15pm
8-K
EX-99.2
ik1xu6wc
9 Nov 23
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:15pm